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INTRODuCTION
Cancer of the colon and rectum (colorectal 
cancer, CRC) is ranked second in prevalence rate. In 
men, it comes second after lung cancer, and in women 
it comes second after breast cancer. Ages  between 50 
and 70 years are most often affected, and it is slightly 
more frequent in males than in females. There is a 
steady trend of annual increase of incidence rate in 
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ABSTRACT
PurPose: The terms of ‘unresectable’, ‘inoperable’ and ‘incurable’ cancer/patient are widely used but not 
clearly defined and thus subject to significant subjectivity. Where is the limit of ‘resectability’ of colorectal 
cancer - the criteria are variable and not precisely defined yet. locally advanced lesion may vary from vis-
ible intimately adhered to the surrounding tissue, i.e. marginal, ‘border’ resectable tumour to one that di-
rectly macroscopically engages adjacent critical structures. This paper presents the experience of other for-
eign authors with their results in the determination of the tumour as resectable or unresectable as well as 
own clinical experience in this field. 
MATerIAl ANd MeTHods: The study covered the patients with colorectal cancer who were operated in 
the Clinic of surgery during a period of 9 years and retrospectively analyzed. 
resulTs: out of a total of 1051 surgeries on the occasion of colorectal cancer, advanced disease constituted 
28,6% or 301 patients. of them, 52,5% were localized in different parts of the colon. Fifty-eight combined re-
sections were performed as in 7 of them (recurrent tumours) r1 was accomplished, i.e. a non-radical result. 
A total of 117 cases were assessed intraoperatively as non-radical surgery and palliative procedures were per-
formed such as resections (with or without restoration of the intestinal passage, but in the case of M1), by-
pass anastomoses, or simple interruption of the passage. .
CoNClusIoN: Many of the world’s leading surgical centres adopt the tactics of ‘adequate aggressive behav-
iour’ for locally advanced primary and recurrent colorectal cancer. In determining the reasonable balance 
between aggressive approach and the so-called meaningless ‘surgical exorbitance’ there is strive to adhere 
to the view that failure to achieve r0-resection planed in such an operation as well as leading performance 
or a combination of factors such as advanced age, severe co-morbidities, presence of complicated forms of 
colorectal cancer, urgent intervention and data of generalization of the malignant process undermine the 
performance of aggressive block removal of tumour formation. However, adequate pre- and intraoperative 
assessment and surgical experience should avoid ‘exaggerated’ intraoperative status of locally advanced tu-
mour and passive determination as ‘unresectable’.
Key words: colon cancer, resectability, primary colon cancer, locally recurrent colon cancer, surgery
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Bulgaria of 18,6 per 100000 inhabitants in 1984 up to 
26,7 per 100000 in 1993. According to the National 
Cancer Registry for 2009, the incidence rate of colon 
cancer in men is 40,4/100000 and 32,2/100000 in 
women. The distribution of cancer of the rectum 
and anus is 30,5/100000 in men and 19,7/100000 in 
women, respectively. Colon cancer mortality rates 
are 11,8/100000 in males and 7,0/100000 in females, 
while those of cancer of the rectum and anus are 
10,2/100000 and 3,8/100000, respectively (1). CRC is 
often curable disease when localized only in the gut 
wall. Surgery is the primary manner of treatment 
and cure is achieved in approximately 50% of the 
patients. Relapse after surgery is a major problem 
and is often the ultimate cause of death.
Locally advanced primary and recurrent CRCs 
are surgical challenge due to clinical presumption of 
tumour involvement of other structures and organs. 
Anticipated need for extensive surgical resection, of-
ten with multivisceral en-bloc resection is crucial for 
preoperative surgical planning. As for the primary 
and the recurrent tumors, postoperative long-term 
survival is achievable, but only after complete R0-re-
section. The role of neoadjuvant and adjuvant thera-
py continues to be seen in this era of biological che-
motherapies and multimodal treatment provides an 
opportunity for the technical realization of resection 
and improves long-term survival. 
According to the prospective SEER (Surveil-
lance, Epidemiology, and End Results) program data 
in the USA from 1992 to 2003, staging and survival of 
almost 36000 patients with rectal cancer and 110000 
ones with colon cancer analysis presented at the an-
nual meeting of the American Society for Clinical 
oncology in Chicago (2008 ASCo Annual Meeting), 
among the patients with tumour at IIB stage which 
extends through the intestinal wall and infiltrates 
the surrounding structures, no metastases to lymph 
nodes (T4 N0 M0) there is a worse chance of survival 
than among those with tumour at III stage which re-
mains in the intestinal wall, but spreads to the lymph 
nodes (T1-2 N1-2) (2). Recent studies confirm that T4 
stage is an important independent prognostic fac-
tor for disease-free interval and overall survival (3). 
Based on this, AJCC Hindgut Taskforce (HTF) vali-
dates change staging as stage IIB is divided into two 
substages: IIB T4a tumours are passing through the 
outermost gut layer (visceral peritoneum) and IIC 
T4b, where the tumour directly infiltrates other or-
gans or structures. Stage IIC has a significantly worse 
chance of survival than stage IIB, IIIA or IIIB. Fur-
thermore, some tumours that have spread to more 
than three lymph nodes (N2) are less likely to lead 
to death in the next five years than it was previous-
ly suspected and should be reclassified as IIIA (4). 
This population-based analysis of the survival vali-
dates rectal pooled analysis data analysis (5) and de-
termines the change of T1-2N2 cancer from IIIC to 
IIIA/IIIB and T4bN1 from IIIB to IIIC. It also sup-
ports splitting IIB in IIB (T4aN0) or IIC (T4bN0) and 
displacement of favourable TN2 categories IIIC to 
IIIA (T1N2a) or IIIB (T1N2b, T2N2a-b, T3N2a, T4a-
N2a). The results of the TN category involve complex 
biological interactions between the depth of the pri-
mary invasion and lymph nodal status (6).
The determination of the colon cancer as local-
ly advanced stage of the disease is necessary in order 
to achieve practical and theoretical clarity concern-
ing a considerable percentage of patients presenting 
for treatment to the surgeon. Some patients with co-
lon cancer present with a different form and extent of 
locally advanced or recurrent primary tumour pro-
cess, but in a stage of non-metastatic disease, which, 
despite the lack of generalization, it may be resected. 
Criteria of unresectability are variable and not clear-
ly defined yet. Locally advanced tumours defined by 
some authors as such are visualized by endorectal 
ultrasound as T3/4 or N1 tumours, or ones that are 
clinically diagnosed through physical examination, 
but without any distant metastases (7,8). The Ameri-
can Joint Committee on Cancer staging schema clas-
sify them as T4 lesions (9).
An appropriate working definition of locally 
advanced CRC is that the final evaluation of the mul-
tidisciplinary team managing the patient presented 
by surgeons, pathologists, radiologists, medical on-
cologists, gastroenterologists and imaging diagnos-
tic specialists is precise and standard single-organ re-
section could be made, no more likely to remain in 
the specimen of the surrounding tissue and spaces 
of microscopic or macroscopic residual disease de-
tectable due to adherence or fixation of the tumour 
to the surrounding structures. Locally advanced le-
sion may vary from visible intimately adhered to the 
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surrounding tissue, i.e. marginal, ‘border’ non-re-
sectable tumour to one that directly macroscopically 
engages adjacent critical structures (e.g. main dishes, 
duodenum, pancreas, pelvic bones, lateral or anteri-
or abdominal wall, other parts of the colon or small 
intestine or its mesentery, internal genitalia or organs 
of the urinary system, nerve plexuses, etc.). Usually, 
locally advanced cancer of the left colon may direct-
ly infiltrate the left kidney, spleen, abdomen, stom-
ach and distal pancreas. Sigmoid cancer may invade 
into the bladder, ovaries, and uterus. Right-sided co-
lon cancer can affect liver, pancreas, duodenum, and 
right kidney. A case of advanced right-sided colon 
cancer in engagement with the duodenum or pan-
creas, or both, is a dilemma for colorectal surgeons. 
Preoperative imaging methods are often unable 
to provide accurate information about the duodeno-
pancreatic invasion. Upper gastrointestinal endosco-
py may fail to identify duodenal infiltration because 
tumour infiltration may be limited to the muscle lay-
er without macroscopic invasion of duodenal lining. 
In this particular situation, intraoperative decision to 
perform pancreatoduodenectomy is difficult. Tumour 
mass is usually too big to adequately characterize the 
tumour boundaries. Patients with limited effect on the 
wall of the duodenum can be safely treated by partial 
resection and subsequent plastics, while for some larg-
er parts of duodenal wall or pancreas pancreatoduode-
nectomy is required (10). Literature data indicate that 
most surrounding structures and organs are affected 
at primary site of the tumour in the sigmoid colon and 
rectum – in 66-89% of cases. Reasons are the high in-
cidence of carcinoma localization in these areas, the 
mobility of sigma and close spatial proximity of the 
structures in the pelvis (10-13). Defining the locally 
advanced stage of the disease depends on a clinical as-
sessment of resectability, pre-operatively or intraoper-
atively. In some cases, ‘inoperable’ tumour assessed as 
such in clinical or radiographic imaging studies may 
with subsequent intraoperative exploration be ame-
nable to curative resection (8). ‘Locally advanced’ tu-
mours represent 5-22% of all CRCs (14,15). The lack 
of local tumour control, especially in locally advanced 
CRC has disastrous consequences such as intestinal 
or urinary obstruction, bleeding from the lower gas-
trointestinal tract, morphological and functional dis-
orders of the other surrounding organs, fistulizations 
and considerable pain. Successful eradication of local-
ly advanced CRC would provide better survival and 
quality of life. Many researchers report in a number of 
cases the possibility of en-bloc resection (14,16-18) and 
some of them demonstrate significantly better long-
term prognosis and actual survival.
Complete removal of the tumour by achieving 
a negative resection lines is critical to obtain long-
term results in terms of survival and, generally, fre-
quently requires multivisceral block resection. This 
needs focusing on clinicopathologic features associ-
ated with such co-morbidity and predictors of long-
term survival in patients undergoing surgery for lo-
cally advanced and locally recurrent CRC, together 
with the established role of neoadjuvant or adjuvant 
chemotherapy and radiation. As highlighted, the 
benefits on survival and quality of life after multiv-
isceral resections are often associated with markedly 
higher postoperative morbidity rate (11,19,20), how-
ever, because of improved surgical technique and ex-
perience, the complications gradually reach the level 
common in non-block resections (15,21).
In about 10% of colon carcinoma cases, tumour 
conglomerates affect adjacent structures. Histologi-
cally demonstrable permeation, however, is only in 
about 50% of these cases, with the remainder being 
caused by adhesion due to peritumoural inflamma-
tion. In both cases, a multivisceral resection in unit 
is necessary to remove all structures involved, as the 
goal is to achieve R0 resection taking into account the 
ways of the lymphatic drainage of all the bodies in-
volved. The complete resection is a prerequisite for 
long-term survival. In the case of locally advanced 
colon cancer, the determination of the difference be-
tween the benign and malignant invasion adhesions is 
often not possible in the operating room. Since dissec-
tion of malignant fistula or infiltration and disruption 
of tumour integrity are associated with tumour dis-
semination and poor outcome due to early local recur-
rence and reduced survival, en-bloc resections of the 
affected structures are widely recommended. In most 
cases, this may require multiple organ resection, but 
safe treatment is possible only if it achieves R0-resec-
tion. If the organs involved in primary tumour con-
glomerate are intraoperatively separated, histological 
confirmation of true infiltration can intraoperatively 
be obtained, e.g. in case of carcinoma located in the 
right flexure involving pancreatic head before a deci-
sion is made to perform a combined pancreaticoduo-
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Table 1. role of imaging examinations in crc
denectomy increasing the risk of locoregional recur-
rence or peritoneal carcinomatosis due to the gener-
alization of tumour cells in the abdominal cavity, by 
about two times. The possibility of indeterminable or 
false-negative results by gefrire examination should 
not be underestimated. Therefore, multiorgan resec-
tion is undertaken only in cases when it can be avoid-
ed through the tumour mass and tumour cell scat-
tering. Proper interpretation of the physical signs and 
symptoms of multivisceral involvement and appropri-
ate use of preoperative imaging ensure that a multidis-
ciplinary oncology team would make the correct deci-
sion in order to direct the surgeon to extended resec-
tion when necessary. Similarly, achievement of com-
plete resection of locally recurrent CRC is essential for 
long-term survival. Dissection of the structures often 
challenges because of the deletion of anatomical plans 
following the previous operation, which represents a 
significant technical difficulty to multivisceral resec-
tion. Implanting radiopositive marker clips can be 
useful in mapping the areas of dissection, when post-
operative radiotherapy is intended.
The majority of patients with locally advanced 
tumours present with symptoms such as back or lum-
bar pain, nausea or vomiting indicating some degree 
of obstruction or frank haematuria. Frequently, symp-
toms target localization of disease, e.g. bladder inva-
sion is associated with dysuria and haematuria and in 
case of pathological fistula there is gas in the bladder 
through the urethra and in micturition as well as leak-
age of urine through the anus. As might be expected, 
the most frequently implicated tumour pathologies 
are anatomically similar to the primary lesion: cecum 
and sigmoid carcinomas are usually associated with 
the ovaries, fallopian tubes, uterus, and small intes-
tine, whereas hepatic flexure, or transversal colon-li-
enal flexure more frequently infiltrate gallbladder, du-
odenum, stomach, pancreas, and spleen. The abdomi-
nal wall is more likely to be affected by intraperitone-
al parts of the colon, and the retroperitoneum is more 
likely to be infiltrated by the lesion located in the two 
folds or ascending and descending colon.
Locally advanced lesions generally are larger 
and often palpabale on physical examination. Colo-
noscopy can reveal, to varying degrees, annular ste-
nosing or obstructing constriction bands, usually 
bleeding easily when touched. Image data from com-
puted tomography (CT), magnet resonance imaging 
(MRI), and positron-emission tomography (PET)-
CT often show suspicion of infiltration or presence 
of subtle malignant fistula. They could not, howev-
er, distinguish between peritumoural inflamma-
Purpose Accuracy
  CT MRI PET
Initial preoperative staging 48-77%    
T-staging of rectal cancer 77% 85%  
Detection of liver metastases 73-82%* 82-97%* 77-92%
N-staging 23-73% 85%  
Imaging vascular anatomy for planning resection 
(recommended)
   
Staging of recurrent disease sensitivity of 46-69% 
specificity of 96%
  sensitivity of 79-93% 
specificity of 96%
*if severe steatosis is present, accuracy for detecting liver metastases drops to 48% by cT and to 70% by Mri
*PeT does not play any role in initial staging unless extrahepatic disease is suspected or results from other imaging modalities are 
equivocal.
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tion by direct tumour infiltration in the absence of a 
100% ‘sensitivity’ and ‘specificity’ of these diagnostic 
methods. Ultimately, the surgeon must intraopera-
tively decide whether it is necessary and whether it is 
technically possible to perform combined resection. 
Table 1 compares the diagnostic capabilities of 
these imaging methods in patients with CRC (24).
Lymph node size of 3-6 mm is considered 
intermediate (undefined); >6 mm - suspected; >8 
mm -malignant. 3T MRI is more accurate than 1,5T 
image. Enhanced diffusion MRI technique (diffu-
sion-weighted MR imaging, DWI) possesses the larg-
est diagnostic capabilities compared to other modali-
ties in determining the N-status (24).
Prognosis of locally advanced tumours is not 
poor when they are fully resected in tight. A more dif-
ficult situation arises when the combined resection 
involves higher risk procedures such as partial du-
odenectomy and/or duodenohemipancreatectomy. 
Eight cases of T4 tumour formations of the right co-
lon requiring pancreatic or duodenal resection were 
reported (25). Either a right colectomy to block duo-
denectomy (n=4), or pancreatoduodenectomy (n=4) 
were performed to ensure R0 resection. There were 
only two non-severe complications and no deaths. 
Six patients remained ‘free’ of the disease at an aver-
age follow-up of 26 months, and one - during a ‘dis-
ease-free’ period of 84 months. In another study (11), 
12 patients underwent partial block duodenectomy 
(n=5) or pancreatduodenectomy (n=7) for resection 
of colonic cancer. Eight patients were described as 
‘free’ of the disease at an average of 42 months fol-
low-up. A ‘disease-free survival’ for a period of 10 to 
113 months was reported elsewhere (26). These rates 
provide evidence in support of the aggressive behav-
iour in resection of adjacent organs, including the 
pancreas, for locally advanced colon cancer provid-
ed that it can be performed with an acceptable lev-
el of morbidity and mortality rates. When a surgeon 
is not willing to take an extended resection it is bet-
ter the patient being taken to a centre with sufficient 
experience in multivisceral resections than being al-
lowed to conduct an incomplete (R1 or R2) resection.
Urgency of the transaction often triggered by 
complications typical for locally advanced CRC has 
been identified as an independent risk factor for poor 
outcome in terms of long-term survival (23). The pos-
sibility of conservative management of specific com-
plications when it is real and not associated with in-
creased risk for the patient would allow conversion of 
the emergency procedure into elective surgery after as-
sessment by a multidisciplinary team and with favour-
able conditions for the implementation of complete 
mesocolic excision (CME) with a radical operation.
Primary anastomosis in case of tumour ob-
struction of locally advanced colon cancer in left-sid-
ed positioning can be performed only when the ileus 
dilation is in an initial stage, the walls of the proximal 
bowel are not overstretched and lack any evidence 
of bacterial translocation and peritonitis, as well as 
risk profile such as age, homeostasis abnormalities 
and co-morbidities is favourable. obstruction in ad-
vanced and high risk cases should be managed by dis-
continuity operation of Hartmann. According to var-
ious authors, protective proximal stoma, primary re-
section and anastomosis do not provide any advan-
tage. Data from the multicentre study (27) present an 
assessment of the status of the surgical treatment of 
malignant obstruction of locally advanced cancer of 
the left colon in Germany and compare different op-
erational approaches in the emergency treatment of 
this complication, especially diversionary operations 
(Hartmann procedure) and primary anastomosis. 
Among 15911 patients with cancer of the left colon 
reported between 2000 and 2004, a total of 743 pa-
tients underwent emergency surgery for malignant 
obstruction caused by locally advanced cancer, who 
had undergone radical resection. These patients were 
compared with respect to their risk profile and post-
operative results. In 57,9% (n=430) a single-step rad-
ical surgery (group I) was done, in 11,7% (n=87) - a 
primary resection anastomosis with outlet protecting 
stoma (group II), and in 30,4% (n=226) - a diversion-
ary Hartmann procedure (group III). In group III, 
most patients were male, with overweight, polymor-
bidity and more advanced tumours. Hospital mor-
bidity and mortality (e. g., overall hospital mortality 
of 7,7%; n=57) did not differ significantly between the 
three groups. Preventive placement of temporary pro-
tective stoma did not influence on the rank of anasto-
motic insufficiency (group I, 7% and group II, 8,0%).
Local recurrence after primary CRC treatment, 
per se, is also variable concept concerning the accep-
tance by surgeons. It would appear as:
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- local recurrence with the same histological 
characteristics or negative grading progressed to-
wards low differentiation, the site of anastomosis 
in previous comprehensive surgery - resection with 
subsequent reconstructive stage anastomosis, or
- locoregional recurrence - in the surrounding of 
the primary tumour removed - in incomplete R1 re-
section or inadequate removal of regional and lymph 
vessels or lymph-node pool, extensive perineural in-
vasion, not covered in the removed specimen, iat-
rogenically implanted tumour bed in tumour cells 
(however, no No-Touch rule Turnbull is responsible 
for both locoregional recurrence and generalized or-
gan metastasis through blood and lymph channels, 
and implantation metastasis throughout the opera-
tive field and surgical wound) (22).
Approximately 40% of the patients with 
resected colon cancer develop recurrence and most 
of them exhibit initially distant spread of the disease. 
Locoregional recurrence is much less common and 
accounts for 10% to 20% of recurrent cases. Cause 
of local recurrence include incomplete resection 
of transmural or lymphatic dissemination of the 
disease, integrity of the tumour or implantation of 
tumour cells. Surgery remains the primary treatment 
method, but it is clear that (R0)-resection can achieve 
long-term survival only.
The largest series of sweeping operation 
of locoregional recurrences were reported from 
Memorial Sloan-Kettering Cancer Center (MSKCC) 
(28) and Mayo Clinic (29). MSKCC series describe 
100 patients and Mayo Clinic series report 73 
patients. In two series of patients who have initially 
undergone a particular type of primary resection of 
tumour-bearing part of the casing, and subsequently 
developed locoregional recurrence, respectively, 
laparotomy was done as an intended curative 
resection of recurrences. In MSKCC series, the main 
reasons that led to relapse are generally advanced 
tumours extending through the intestinal wall, T3 or 
T4 were present in 85%, obstructing colon tumours 
were found in 11% and tumour perforation in 13%. 
Both studies confirmed that the majority of the 
primary tumours were located distally to the left 
flexure. Metastases in the lymph nodes were noted 
only in 50% of patients in the MSKCC study and in 
60% in Mayo Clinic one, which indicated that the 
mechanism for the development of locoregional 
recurrence usually involved incomplete primary 
resection of the tumour in widespread area. 
This hypothesis is supported by the large-scale 
retrospective series of patients with colon cancer in 
which locoregional recurrences are envisaged on the 
basis of nodal status of primary disease. 
Subgroup of patients with stage II CRC is 
considered to be that with the highest degree of 
risk of relapse/metastatic disease on the basis 
of: 1) tumour obstruction/perforation, 2) <10 
removed lymph nodes at surgery, 3) T4 lesions 
and 4) invasion of the lymphatics or blood vessels 
(30). Their prediction is considered comparable to 
that of patients with stage III (T1-4 N + M0) and, 
therefore, it is highly recommended to use them with 
adjuvant chemotherapy. MSKCC and Mayo Clinic 
are similar concerning the classification of disease 
recurrences by dividing them into four groups. 
They are perianastomotic (intramural disease), 
mesenteric (involvement of regional lymph nodes), 
retroperitoneal (implantation metastasis, distant 
nodal disease or transmural residual disease), and 
peritoneal (implantation metastasis). When a relapse 
is detected, there is often a significant overlap and 
uncertainties in these categories. However, this 
scheme has its prognostic significance (28,31). In 
MSKCC series perianastomotic unilateral recurrenc-
es prevail (in 36%) followed by peritoneal (in 16%), 
mesenteric (in 15%), and retroperitoneal (in 12% of 
the cases). It is not surprising that two synchronous 
recurrent formations are noted in 21% of cases, 
with the most common combination involving 
anastomosis and regional peritoneum. Interestingly, 
the localization of the relapse associated with the 
clinicopathologic characteristics as the left-hand 
primary tumour is more commonly associated with 
recurrent anastomosis and the clinical obstruction is 
associated with peritoneal dissemination of disease 
relapse.
Mayo Clinic series attempt to delineate more 
precisely the different types of lymph node location 
on the form of relapse. Although some cases of relapse 
are due to inadequate resection with mesenteric 
lymph node dissection, most recurrent sites of lymph 
nodes are in regions which are not included in the 
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standard oncological resections of colon (t.e. aortic, 
celiac, and iliac lymph group).
Surgical results in locally recurrent colon cancer 
In the MSKCC series of 100 patients undergoing 
surgery with curative purpose, 56 patients underwent 
complete resection en-bloc. Thirty patients underwent 
incomplete resection as 11 were with microscopic 
and 19 with macroscopic residual disease. Fourteen 
patients were considered unresectable at exploration. 
Complete resection in 41 patients consisted in en-
bloc removal of the tumour with surrounding organs 
or structures, usually in the abdominal wall, ureter, 
kidney, stomach, uterus, and pancreas. Nine patients 
underwent resection of multiple organs. Twenty-six 
patients had distant synchronous condition judged 
resectable. overall, 21 of these patients underwent 
complete remote metastasectomy. The average 
hospital stay was 9 days, operative mortality rate 
was 1%, and perioperative morbidity rate was 24%. 
The incidence was highest (36%) among 14 patients 
considered inoperable during operation. Thirty-one 
patients received extracorporeal and/or intraoperative 
radiation therapy as part of a treatment plan.
The result of the operation in cases with cu-
rative locoregional recurrence is closely related to 
‘completeness’ of the resection. In the MSKCC series, 
statistical 5-year survival for the entire cohort was 
35%, with a median survival of 30 months. In 56 pa-
tients with complete (R0) resection, 5-year survival 
is 58% and the median survival time was 66 months. 
Incomplete resection, or as a result of microscopic 
(R1) or macroscopic (R2) residual disease is associat-
ed with significantly worse results. The median sur-
vival for patients with R1 (n=11) and R2 (n=19) resec-
tion is 25 and 23 months, respectively. There was no 
5-year survival in cohorts of patients who underwent 
incomplete resection. In this series, 14 patients with 
laparotomy deemed unresectable and their median 
survival was less than 12 months.
In addition to the completeness of resection, 
MSKCC series describe several factors that pre-
dict outcome after curative operation, including the 
number of recurrences, location, pre- and postoper-
ative CEA values, age, details of distant disease and 
stage of the primary tumour. Classification scheme 
for local recurrences also determines the predicted 
outcome. Patients with more than one location on 
locoregional recurrence and those with evidence of 
mesenteric recurrence have poorer results than with 
anastomosis, retroperitoneal or peritoneal relapses. 
The presence of synchronous distant metastases has 
an adverse outcome, too. However, 12% of patients 
with distant spread and local recurrence are living 
longer than 5 years after curative resection, indicat-
ing that the presence of the synchronous solitary dis-
tant metastasis is not a contraindication for curative 
operation provided that it is technically possible to 
remove the metastasis in tight. Time to recurrence 
is not a significant predictor of the outcome, which 
is somewhat surprising, since prolonged disease-
free interval assumes more favourable tumor biology 
(32). This can provide impartial data that is inherent 
in retrospective studies (33). No doubt that the de-
gree of ‘enlargement’ of resection and number of ad-
jacent organs removed during surgery does not affect 
the result as long as R0 resection is achieved.
Mayo Clinic series included 73 patients who un-
derwent surgical exploration for locoregional recur-
rence. Complete resection was achieved in 52% of 
them. Incomplete resection such as macroscopic and 
microscopic residual disease was done in 26% and 
22% of the cases, respectively. on average, 51% of pa-
tients had complications, 70% were small and 30% se-
vere, including one patient with perioperative death. 
All the patients received either external beam radia-
tion and/or intraoperative radiation in the course of 
their treatment. For the entire cohort, statistical 5-year 
survival was 25% and median survival was 33 months 
(reported from the time of diagnosis of recurrence). 
Complete (R0) resection was performed in 38 patients 
(52%) and was associated with a significant improve-
ment of the 5-year survival in 37% of the cases. Thir-
ty-five patients underwent incomplete resection - 19 
with microscopic (R1) and 16 with macroscopic (R2) 
residual disease. There was no statistically significant 
difference in the cohort of patients resected incom-
pletely, with 25% of 5-year survival rate and lack of 
a 5-year survival rate in the R2 group. These results 
highlighted the well-described link between quality 
of resection (R0, R1, and R2) and output. Long-term 
survival was rare, if it existed at all, in patients with 
partial resection. It turned out that all the residual tu-
mour areas - macroscopic and microscopic, negatively 
affected the results. The challenge for the clinicians is 
to determine which patients may be evaluated to un-
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dergo complete surgical resection and thus to prevent 
incomplete resection, which simply slows the applica-
tion of other, non-surgical treatments.
MSKCC series was large enough to identify 
factors associated with complete (R0) resection of 
locoregional recurrence. Among the patients with a 
single location of the disease, perianastomotic form 
(unlike the mesenteric, retroperitoneal or peritoneal) 
of recurrence, low preoperative CEA and absence of 
distant metastases were more likely to be the cause 
of long ‘disease-free’ interval after a successful 
operation. Although not absolute, these factors can 
be identified on the preoperative tests, which would 
help the evaluation of patients for surgical success. 
In the patients with peritoneal disease and nodal/
mesenteric form of relapse in more than one location, 
elevated CEA and synchronous distant metastatic 
disease hamper to achieve complete curative 
resection and in such cases, preference is given to 
neoadjuvant therapy prior to surgical resection.
MATERIAL AND METHODS
Retrospective analysis of patients with proven 
CRC surgery at the Clinic of Surgery, Alexandrovs-
ka University Hospital of Sofia Ltd for the previous 9 
years was carried out. Documentary evidence from 
patient’s history, operative reports, operational logs 
were used. Data from the Clinical Centre of Anat-
omy at the same university hospital where the his-
tological examinations and pathologic staging were 
performed were analyzed. Protocols from special-
ized oncology hospital committees with final stag-
ing of patients and decisions of oncology committee 
were examined. Statistical data processing was per-
formed with IBM SPSS software.
RESuLTS
The operational activity was on an average of 
1100 operations per year. During the 9-year period, a 
total of 1051 surgical patients with histologically veri-
fied CRC were treated. Cases of advanced malignancy 
accounted for 28m6% or 301 patients. The average pa-
tient’s age was 67,4 years. of them, 68% were males and 
32% females. In 552 operated patients (52,5%), can-
cer was located in different parts of the colon. There 
were 175 patients with locally advanced colon cancer, 
32 recurrent and 143 - primary. In 58 patients, com-
plete combined resection of locally advanced tumour 
block infiltrating the surrounding structures and or-
gans was performed. In 7 of them, the final histolog-
ical results showed failure to achieve radical excision 
of infiltrative surrounding tissues (R1). They were re-
current tumours with massive infiltration of large ar-
eas. Some 117 palliative (non-radical) interventions 
were performed - in 90 patients, inability of radical 
surgery was caused by pre- and intraoperative detec-
tion of a generalized cancer process, bilobar unresect-
able multiple liver metastases and/or diffuse carcino-
sis of peritoneum. In the remaining 27 patients, the 
decision about inability of radical resection of carci-
noma was caused by the general extraorgan infiltra-
tion of surrounding structures - in 18 patients with in-
traoperative assessment of the lack of sufficient prob-
ability of achieving R0-resection, while in the remain-
ing 9 ones the reason was urgency of intervention due 
to serious complications (mostly obstruction or per-
foration - tumour or diastasis with diffuse peritoni-
tis or total one) and/or advanced age with severe de-
compensated comorbid background. Although in 34 
of these 117 non-radical surgical cases resection of 
the primary tumour was performed (in the technical 
possibility and preserved functional status of other 
organ systems), the presence of irremovable distant 
metastases characterized the operation as a palliative.
DISCuSSION
Many eminent surgical centres promote the 
idea of  ‘adequate aggressive behaviour’ for locally ad-
vanced primary and recurrent CRC (34). However, 
this inevitably requires individualized and compre-
hensive assessment of each case based on the use of 
the full resources of diagnostic methods for preop-
erative staging, as well as a broad discussion of the 
results of a multidisciplinary team before undertak-
ing the operation. our vision largely overlaps with 
the opinion of most of these authors about the cir-
cumstances that determine the decision for unre-
sectability of locally advanced CRC. In our practice, 
we performed a combined removal of colon tumour 
and duodenopancreatic resection of the infiltrated 
sections of the duodenum or the head of the pancre-
as. There are benefits of long-term survival and dis-
ease-free interval/intra- and postoperative compli-
cations. In contrast to other studies (11,25,26), the 
small number of our patients operated on and fol-
lowed did not warrant any representativeness of the 
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sample. Along with assessing the status of all vital 
organs and systems, evidence or lack of generaliza-
tion of the process, presence of complicated forms of 
CRC and emergency or planned manner of opera-
tion, macroscopic features of malignancy as assessed 
with intraoperative exploration prove decisive for 
their assessment of resectability, which depends very 
much on the experience of the operating surgeon re-
sponsible for the patient. In 27 of our patients, factors 
such as extent of the estimated gross infiltration en-
gagement, missing critical structures and/or worsen-
ing performance-status because of severe comorbidi-
ties favouur the decision that ends ‘aggression’ per se 
would be unnecessary and even harmful to patient’s 
short-term and long-term prognosis. 
opinion of all authors, including ours, to con-
solidate the idea that failure to achieve R0-resection 
undermines the performance of aggressively block 
removal of tumour formation, while simultaneous-
ly, pre- or metachronous removal of oligometastases 
in the liver remains controversial. In 7 of the local-
ly advanced recurrent tumours, block resection with 
intraoperative macroscopic presumption of radical 
surgery were committed, but the final histological re-
sults showed microscopic infiltration in some areas 
of the excised infiltration. Since it is a massive infil-
tration at the ‘edge’ of technical ability and poor gen-
eral condition of the patients, some of them elderly, 
no re-Redo surgery could be reached to achieve his-
tological, i.e. real radicality. All the authors empha-
size the adequate consensus, called ‘team’ preopera-
tive approach. In our practice, unfortunately, is not 
perceived by the Cancer Committee to report and 
treat patients in the phase before any operation. Es-
pecially in recent years, a limitation and complex use 
of the full range of highly specialized and high-tech-
nological diagnostic imaging methods are reasons of 
subjective and objective nature as the economic rea-
sons are leading. Most authors adopt the view con-
cerning the indications of combined preoperative 
chemotherapy in order to increase the possibility of 
planning the operation as ‘potentially curative’.
Preparation is imperative to validate a 
standardized strategy for management of patients 
with advanced (locally or generalization) CRC, 
delineating and clearer criteria for resectability 
and, consequently, unresectability of the primary 
or recurrent tumour, and for the prospects of 
neoadjuvant therapy.
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